"永信"適汎黴素膠囊

Nazione: Taiwan

Lingua: cinese

Fonte: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Principio attivo:

CEPHALEXIN

Commercializzato da:

永信藥品工業股份有限公司 台中市大甲區頂店里中山路一段1191號 (56065601)

Codice ATC:

J01DB01

Forma farmaceutica:

膠囊劑

Composizione:

CEPHALEXIN (0812301300) (262.5MG) 250MG

Confezione:

鋁箔盒裝;;玻璃瓶裝;;罐裝;;塑膠瓶裝

Classe:

製　劑

Tipo di ricetta:

須由醫師處方使用

Prodotto da:

永信藥品工業股份有限公司台中幼獅三廠 台中市大甲區工六路２６號，工十路１２之１號 TW

Area terapeutica:

cefalexin

Indicazioni terapeutiche:

對本劑敏感性細菌所引起的下列感染症、細菌性心內膜炎、淺在性化膿性疾患、深在性化膿性疾患、下呼吸器感染症、性器感染症、尿路感染症、耳鼻科領域感染症、眼科領域感染症、其他：敗血症、產褥敗血症、褥瘡、腹膜炎、肋膜炎

Dettagli prodotto:

有效日期: 2025/04/16; 英文品名: CEPHANMYCIN CAPSULES "YUNG SHIN"

Data dell'autorizzazione:

1976-04-16

Foglio illustrativo

009453
Code No.:32004
CEPHANMYCIN
CEPHANMYCIN
Capsules "Yung Shin"
Capsules "Yung Shin"
Cephalexin
7-(D-
-Amino-
-Phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid
Cephalexin
........................................................................................................
250mg (potency)
Colloidal silicon dioxide
Lactose
Magnesium Stearate
Talc
Sodium Starch Glycolate
、
Capsule #2
(Gelatin
、
Sodium Lauryl Sulfate
、
Brilliant Blue FCF
、
Iron Oxide Yellow
、
Titanium Dioxide)
。
1.
(action mechanism)
2.
(Staphylococci)
(Hemolytic streptococci)
(Diplococcus pneumoniae)
(Corynebacterium diphtheriae)
(Streptococcus pyogenes)
(Escherichia
coli)
(Klebsiella pneumoniae)
(Proteus mirabilis)
(Haemophilus influenzae)
(Salmonella)
(Shigella)
3.
(Cephalosporinase)
-Lactam ring
4.
(Cross resistance)
5.
6.
250mg (potency)
1
9mcg/mL
6
6
8
90%
24
Cephalexin
20kg
6
250mg
6
500mg
1.
2.
(SUPER-INFECTION)
3.
4.
2
3
GROUP A
-HEMOLYTIC STREPTOCOCCUS
(EOSINOPHILIA)
(NEUTROPENIA)
SGOT
SGPT
1.
2.
25
3.
8
1000
2150441
CCC-006
YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO., LTD.
1
1 1 9 1
2 6
®
®
®
®